Dr. Reddy's Laboratories Limited
RDY
$12.22
$0.110.91%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 7.49% | -18.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.49% | -18.88% | |||
| Cost of Revenue | 4.20% | -3.46% | |||
| Gross Profit | 11.55% | -32.20% | |||
| SG&A Expenses | 3.92% | -2.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 31.09% | -10.45% | |||
| Total Operating Expenses | 4.53% | -4.43% | |||
| Operating Income | 196.35% | -92.38% | |||
| Income Before Tax | 177.85% | -87.85% | |||
| Income Tax Expenses | 651.07% | -105.71% | |||
| Earnings from Continuing Operations | 97.40% | -82.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 2,277.07% | -101.87% | |||
| Net Income | 101.72% | -82.86% | |||
| EBIT | 196.35% | -92.38% | |||
| EBITDA | 75.10% | -75.74% | |||
| EPS Basic | 101.79% | -82.89% | |||
| Normalized Basic EPS | 133.33% | -89.21% | |||
| EPS Diluted | 101.79% | -82.88% | |||
| Normalized Diluted EPS | 133.33% | -89.21% | |||
| Average Basic Shares Outstanding | -0.01% | 0.13% | |||
| Average Diluted Shares Outstanding | -0.01% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||